Recruiting

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(30 sites)

United States

Takeda Site 14, Redwood City, California

Takeda Site 10, Santa Ana, California

Takeda Site 1, Colorado Springs, Colorado

Takeda Site 13, Brandon, Florida

Takeda Site 3, Orlando, Florida

Takeda Site 4, St Louis, Missouri

Takeda Site 8, Denver, North Carolina

Takeda Site 6, Huntersville, North Carolina

Takeda Site 5, Cincinnati, Ohio

Takeda Site 2, Columbia, South Carolina

Takeda Site 7, San Antonio, Texas

Takeda Site 11, Norfolk, Virginia

China

Takeda Site 28, Beijing, Beijing Municipality

Takeda Site 29, Guangzhou, Guangzhou

Takeda Site 27, Shanghai, Shanghai Municipality

France

Takeda Site 17, Montpellier, Hérault

Takeda Site 15, Paris

Italy

Takeda Site 22, Rome, Lazio

Takeda Site 31, Verona, Veneto

Takeda Site 23, Bologna

Japan

Takeda Site 24, Kohoku-ku, Yokohama-Shi, Kanagawa

Takeda Site 9, Kumamoto, Kumamoto

Takeda Site 30, Urasoe-Shi, Okinawa

Takeda Site 20, Shinjuku-ku, Tokyo

Takeda Site 26, Sumida-Ku, Tokyo

Takeda Site 12, Yodogawa-ku, Osaka-shi, Ôsaka

South Korea

Takeda Site 16, Junggu, Daegu Gwang'yeogsi

Takeda Site 19, Suwon, Gyeonggido

Takeda Site 21, Seoul, Seoul Teugbyeolsi

Spain

Takeda Site 18, Madrid